Summary of selected records that assessed attitudes to maternal RSV vaccination
| Record | Title | Location | Sample size | Maternal/Parental RSV vaccine attitudes |
|---|---|---|---|---|
| Holland et al. [63] | Parental awareness and attitudes towards prevention of respiratory syncytial virus in infants and young children in Australia | Australia | 1,992 parents, pregnant/planning, and future parents | High acceptance of maternal RSV vaccination (79.3%) |
| McClymont et al. [64] | Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada | Canada | 723 participants | Acceptance of RSV vaccination during pregnancy is estimated at 77% |
| Cubizolles et al. [65] | Evaluation of intentions to get vaccinated against influenza, COVID 19, pertussis, and to get a future vaccine against respiratory syncytial virus in pregnant women | France | 1,199 pregnant women | Intentions to get vaccinated are estimated at 39.4% |
| Damatopoulou et al. [66] | Prospective attitudes towards respiratory syncytial virus (RSV) vaccine in pregnant women in Greece | Greece | 335 pregnant females | Intention to vaccinate was linked to education, RSV awareness, school-age children, routine vaccine uptake, and previous uptake of COVID-19 vaccines |
| McCormack et al. [46] | Maternal awareness, acceptability, and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland | Ireland | 528 women | 48.5% willing to receive RSV vaccination |
| Miraglia Del Giudice et al. [67] | Respiratory Syncytial Virus: Willingness towards a future vaccine among pregnant women in Italy | Italy | 490 women | 45.9% willing to be vaccinated during pregnancy |
| Wang et al. [68] | Investigating parental perceptions of respiratory syncytial virus (RSV) and attitudes to RSV vaccine in Jiangsu, China: Insights from a cross-section study | China | 2,135 parents of children aged ≤ 14 years old | 70.6% willing to vaccinate their child against RSV |
| Sallam et al. [47] | Attitude to RSV vaccination among a cohort of pregnant women in Jordan: A cross-sectional survey study | Jordan | 404 pregnant women | 77.5% willing to get the RSV vaccination |
| Limaye et al. [69] | RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccines | Kenya | 24 pregnant and lactating persons (qualitative study) | Key concerns centered on vaccine safety and side effects |
| Adhikari et al. [70] | Acceptance of new respiratory syncytial virus vaccine among pregnant women in Nepal for future routine immunization: A descriptive crosssectional study | Nepal | 340 pregnant women | 72.4% preferred maternal vaccination over vaccinating their children |
| Harteveld et al. [71] | Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands | Netherlands | 1,001 pregnant women | 87% likely to accept both maternal and neonatal vaccination |
| Paulson et al. [72] | Protecting against respiratory syncytial virus: An online questionnaire study exploring UK parents’ acceptability of vaccination in pregnancy or monoclonal antibody administration for infants | UK | 1,620 participants | High acceptability (≥ 9/10) for both maternal vaccine and infant antibody if NHS-recommended |
| Beusterien et al. [73] | Healthcare providers’ and pregnant people’s preferences for a preventive to protect infants from serious illness due to respiratory syncytial virus | US | 992 pregnant people | 89.2% chose maternal vaccine or antibodies over no prevention |
| DeSilva et al. [74] | Pregnant persons perceptions and uptake of prenatal RSV vaccine - Minnesota, 2023-2024 | US | 455 pregnant persons participated | 65% intended to vaccinate; 51% received the RSV vaccine |
| Kuntz et al. [75] | Knowledge about respiratory syncytial virus and acceptance of infant monoclonal antibody for RSV and RSV vaccination during pregnancy | US | 1,082 respondents | 70% very likely to accept maternal RSV vaccine |
| Saper et al. [76] | RSV vaccination intention among people who are or plan to become pregnant | US | 1,528 individuals, 18 to 45 years, currently pregnant or planning | 54% very likely to receive RSV vaccine during pregnancy |
| Tucker et al. [77] | Acceptance of the respiratory syncytial virus vaccine in pregnant individuals | US | 111 individuals were eligible for maternal RSV vaccination and were offered the vaccine | 55.9% accepted the RSV vaccine when offered |
RSV: respiratory syncytial virus; COVID-19: coronavirus disease 2019; NHS: National Health Service in England
Malik S: Conceptualization, Methodology, Formal analysis, Validation, Investigation, Resources, Data curation, Writing—original draft, Writing—review & editing, Visualization, Supervision, Project administration, Software. HN: Methodology, Formal analysis, Validation, Investigation, Data curation, Writing—review & editing. AAS: Methodology, Formal analysis, Validation, Investigation, Data curation, Writing—review & editing. Mohammed S: Conceptualization, Methodology, Formal analysis, Validation, Resources, Investigation, Data curation, Writing—review & editing, Supervision, Project administration, Software. All authors have read and agreed to the published version of the manuscript.
The authors declare that they have no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2025.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.